Back | Next |
home / stock / xoma / xoma message board
Subject | By | Source | When |
---|---|---|---|
Nice. Up time again ? Xoma | highstakes | investorshub | 01/08/2019 12:40:01 AM |
Figured that $13 deal wouldn't last long | joe_techi | investorshub | 12/19/2018 8:36:34 PM |
Hmmm xoma | highstakes | investorshub | 11/23/2018 2:34:42 PM |
Received message as a transaction in my account yesterday | joe_techi | investorshub | 11/22/2018 2:10:40 PM |
Wtf xoma | highstakes | investorshub | 10/19/2018 2:00:30 PM |
Wtf bumner Xoma | highstakes | investorshub | 10/18/2018 10:58:39 PM |
Wow xoma | highstakes | investorshub | 10/18/2018 2:48:35 PM |
Boom nice up xoma | highstakes | investorshub | 09/26/2018 2:44:01 PM |
Good news Xoma | highstakes | investorshub | 09/21/2018 12:50:10 PM |
Trading it. Must be. 16-18 range. | highstakes | investorshub | 08/16/2018 12:03:24 AM |
What gives | highstakes | investorshub | 08/13/2018 7:36:53 PM |
Ok this is killing me now. Dang Xoma | highstakes | investorshub | 08/13/2018 7:36:17 PM |
Wozaaa | highstakes | investorshub | 08/08/2018 4:53:00 PM |
Huge news Awsome Xoma | highstakes | investorshub | 06/26/2018 11:49:21 AM |
Huge news Hope this helps Xoma | highstakes | investorshub | 06/26/2018 11:49:04 AM |
Huge news!! Russel | highstakes | investorshub | 06/26/2018 11:48:43 AM |
????huge news Xoma | highstakes | investorshub | 06/26/2018 11:48:21 AM |
$HUGE NEWS CONGRATS!!! Xoma | highstakes | investorshub | 06/26/2018 11:47:35 AM |
I keep looking at it and try and | my name is | investorshub | 04/24/2018 12:51:54 AM |
daily looks nice but we should know by | my name is | investorshub | 04/19/2018 12:25:14 AM |
News, Short Squeeze, Breakout and More Instantly...
Earned $9 million milestone upon U.S. Food and Drug Administration’s approval of Day One’s OJEMDA™ (tovorafenib); XOMA is entitled to receive a mid-single digit royalty on OJEMDA™ sales Acquired Kinnate Pharmaceuticals, adding at least $9.5 million in...
Lexicon Pharmaceuticals (NASDAQ: LXRX) came out with a quarterly loss of $0.20 per share versus the Zacks Consensus Estimate of a loss of $0.18. Th...
Organon, a global women’s healthcare company, initiated XACIATO™ commercial activities in the fourth quarter of 2023 XOMA further expands its late-stage portfolio with synthetic royalty and milestone interests in two additional women’s health assets: Ovaprene ...